EGFR and non-small cell lung carcinoma: Real-time PCR testing of EGFR T790M has been approved for patients with non-small cell lung cancer in whom secondary mutation (T790M) of the EGFR gene is suspected as a result of recurrence or progression and for whom testing of lung tissue specimens is difficult for medical reasons although the selection of subsequent treatments is required.